CD8A and COVID-19: On the other hand, we found that centenarians, COVID-19 patients, and cancer patients after treatment with platinum-based chemotherapy showed elevated frequencies of the terminally differentiated CD28− subpopulation within CD8+ T cells, compared to healthy individuals of similar age range.